Yuying Y Liu, Age 709210 Walnut Glen Dr, Houston, TX 77064

Yuying Liu Phones & Addresses

9210 Walnut Glen Dr, Houston, TX 77064

Cypress, TX

Natick, MA

Columbus, OH

Mentions for Yuying Y Liu

Yuying Liu resumes & CV records

Resumes

Yuying Liu Photo 17

Registered Nurse

Location:
Flushing, NY
Industry:
Hospital & Health Care
Work:
Northwell Health
Registered Nurse
Titan Medical Office P.c Mar 2015 - Sep 2015
Medical Assistant
Kaleida Health Jun 2013 - Jan 2014
Nursing Student
People Inc. Mar 2013 - May 2013
Nursing Assistant
Education:
New York University 2014 - 2016
Bachelors, Nursing
University at Buffalo's School of Public Health and Health Professions 2010 - 2014
Bachelors, Human Services
Skills:
Healthcare, Nursing, Hospitals, Clinical Research, Patient Safety, Time Management, Microsoft Word, Cpr Certified, Bls, Communication, Teamwork, Delegation, Research, Patient Education, Treatment, Emr, Healthcare Management, Medical Billing, Foreign Languages, Microsoft Office, Basic Life Support, Cardiopulmonary Resuscitation, Medicine, Public Speaking, Public Health, Electronic Medical Record
Interests:
Social Services
Health
Languages:
English
Mandarin
Certifications:
Basic Life Support For Health Care Providers, Cpr & Aed
Basic Certificate In Quality & Safety
3T: Interprofessional Teamwork and Collaboration
Advanced Cardiac Life Support
Cpr Certification
American Heart Association | American Stroke Association
Ihi
Nyu Langone Medical Center
Yuying Liu Photo 18

Invoice And One Finance

Work:
Accenture
Invoice and One Finance
Yuying Liu Photo 19

Associate Professor

Location:
Houston, TX
Industry:
Hospital & Health Care
Work:
The University of Texas Health Science Center at Houston
Associate Professor
The University of Texas Health Science Center at Houston Mar 2011 - Aug 2016
Assistant Professor
Education:
China Medical University (Tw)
Bachelors, Medicine
University of Houston
Master of Education, Masters
Peking University Health Science Center
Doctorates, Doctor of Philosophy, Philosophy
Dalian Medical University
Masters
The University of Texas M.d. Anderson Cancer Center
Skills:
Research, Teaching, Clinical Research
Yuying Liu Photo 20

Yuying Liu

Yuying Liu Photo 21

Yuying Liu

Yuying Liu Photo 22

Yuying Liu

Publications & IP owners

Us Patents

Therapeutic Agents Comprising Pro-Apoptotic Proteins

US Patent:
7371723, May 13, 2008
Filed:
May 1, 2006
Appl. No.:
11/415342
Inventors:
Michael G. Rosenblum - Houston TX, US
Yuying Liu - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
C07K 14/00
US Classification:
514 2, 530350
Abstract:
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

Therapeutic Agents Comprising Pro-Apoptotic Proteins

US Patent:
7759091, Jul 20, 2010
Filed:
Feb 29, 2008
Appl. No.:
12/040111
Inventors:
Michael G. Rosenblum - Houston TX, US
Yuying Liu - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
C12P 21/06
C07K 14/00
C07K 16/00
C12N 9/00
US Classification:
435 691, 530350, 5303871, 435183, 4353201, 435325, 514 2
Abstract:
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

Therapeutic Agents Comprising Pro-Apoptotic Proteins

US Patent:
8530225, Sep 10, 2013
Filed:
Oct 25, 2011
Appl. No.:
13/281004
Inventors:
Michael G. Rosenblum - Sugar Land TX, US
Yuying Liu - Pearland TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
C12N 1/20
C12N 15/00
C07H 21/02
C07K 14/00
US Classification:
4352523, 4353201, 536 231, 530350
Abstract:
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

Therapeutic Agents Comprising Pro-Apoptotic Proteins

US Patent:
8043831, Oct 25, 2011
Filed:
May 26, 2010
Appl. No.:
12/788005
Inventors:
Michael G. Rosenblum - Sugar Land TX, US
Yuying Liu - Pearland TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
C12P 21/00
C07K 14/00
US Classification:
435 691, 514 1, 530350, 536 231
Abstract:
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

Therapeutic Agents Comprising Pro-Apoptotic Proteins

US Patent:
2003008, May 8, 2003
Filed:
Jul 17, 2002
Appl. No.:
10/196793
Inventors:
Michael Rosenblum - Houston TX, US
Yuying Liu - Houston TX, US
International Classification:
A61K038/48
A61K039/395
A61K038/18
C12P021/02
C12N005/06
C07H021/04
C12N009/64
C07K016/40
C07K016/22
C07K014/52
C07K014/475
US Classification:
424/094630, 514/012000, 435/069100, 435/226000, 435/320100, 435/325000, 530/399000, 536/023200, 424/146100, 530/388250, 530/388260, 424/085100
Abstract:
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

Cell-Targeted Ikb And Methods For The Use Thereof

US Patent:
2007020, Aug 30, 2007
Filed:
Feb 27, 2007
Appl. No.:
11/679630
Inventors:
Yuying Liu - Houston TX, US
Michael Rosenblum - Sugarland TX, US
International Classification:
C12N 7/00
C12N 5/00
C12N 7/01
C12N 5/02
US Classification:
435325000, 435235100
Abstract:
Activation of nuclear factor kB (NF-kB) is involved in a number of diseases such as viral and bacterial infections, and cell proliferative disorders such as cancer and autoimmune disease. In certain instances, constitutive NF-kB activity has also been liked to the resistance of certain cancers to chemo and radiation therapy. The instant invention concerns method of inhibiting NF-kB activity in target cell populations by deliver of a polypeptide inhibitor of NF-kB (IkB). Methods of the invention may be used to treat diseases such as infections, and cell proliferative disorders. Methods for sensitizing cells to apoptosis and cytotoxic therapies are also described.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.